Sterility Testing

Testing of Critical Product Categories

Covers parenteral and ophthalmic preparations, implants, as well as active ingredients and excipients manufactured under sterile conditions.

Verification of
Absolute Sterility

Confirms the absence of viable microorganisms as a key quality characteristic.

Method-Specific Suitability Testing

Ensures valid results through adaptation and verification of pharmacopoeial methods for specific product matrices.

GMP-Compliant Process Integration

Supports regulatory release and quality control processes throughout the pharmaceutical lifecycle.

Advanced Microbiological Testing

Additional analyses such as microbial identification and endotoxin testing can support investigation and result interpretation.

Proof of absolute sterility in both soluble and insoluble pharmaceutical products.

Methods: Membrane filtration or direct inoculation.

Results: Assessment as sterile or non-sterile.

Suitable for: Sterile pharmaceutical products, medical devices and release testing.

Verification of method suitability for specific product matrices.

Methods: Validation of test conditions and matrix-specific suitability assessment.

Results: Reliable, reproducible and regulatory-compliant analytical results.

Suitable for: Complex products requiring verification of pharmacopoeial test conditions.

Investigation of turbidity, growth indications or atypical sterility test results.

Methods:
Subculture, extended microbiological testing and confirmatory investigations.

Results:
Clear differentiation between contamination events and analytical artefacts.

Suitable for:
Unexpected findings during routine sterility testing.

Identification of detected contaminants to support root cause investigations.

Methods:
Cultivation, MALDI-TOF MS and PCR-based identification approaches.

Results:
Taxonomic classification of microorganisms detected during sterility testing.

Suitable for:
Contamination investigations and corrective action programs.

Assessment of pyrogenic contamination risks associated with gram-negative bacteria.

Methods:
Limulus Amoebocyte Lysate (LAL) Test.

Results:
Quantitative endotoxin assessment for risk evaluation and patient protection.

Suitable for:
Sterile pharmaceutical products, parenterals and critical medical devices.

Sterility testing of pharmaceutical products administered directly into the bloodstream or body tissues.

Typical samples: Injectables, infusion solutions, parenteral formulations and sterile drug products.

Typical applications: Batch release testing, quality assurance and patient safety verification.

Verification of sterility for products intended for direct application to the eye.

Typical samples: Eye drops, ophthalmic solutions and sterile ophthalmic products.

Typical applications: Product release, microbiological quality control and regulatory compliance.

Assessment of sterility for critical medical devices intended for patient contact or implantation.

Typical samples: Implants, sterile medical devices, single-use devices and surgical components.

Typical applications: Compliance testing, product release and contamination control.

Verification of sterile raw materials before use in pharmaceutical manufacturing.

Typical samples: Sterile active pharmaceutical ingredients, sterile excipients and sterile manufacturing materials.

Typical applications: Supplier qualification, incoming goods inspection and GMP-compliant manufacturing.

Sterility-related monitoring of critical pharmaceutical water used in sterile manufacturing environments.

Typical samples: Water for Injection (WFI), purified water and sterile process water.

Typical applications: GMP quality assurance, contamination prevention and process control.

Regulatory Framework

Sterility testing is governed by pharmacopoeial requirements, GMP regulations and internationally recognized quality standards. Together, these frameworks ensure reliable verification of sterility and support patient safety, product quality and regulatory compliance throughout the pharmaceutical product lifecycle.

Request Support

European Pharmacopoeia (Ph. Eur.)
Provides harmonized requirements for sterility testing, method suitability and the microbiological quality assessment of sterile pharmaceutical products.

Ph. Eur. 2.6.1 – Sterility
Defines validated test procedures and acceptance criteria for demonstrating the absence of viable microorganisms in sterile pharmaceutical products and medical devices.

EU GMP Guidelines
Establish requirements for sterile manufacturing, contamination control strategies, aseptic processing and product release.

EU GMP Annex 1
Provides the regulatory framework for contamination control, environmental monitoring and aseptic manufacturing of sterile medicinal products.

DIN EN ISO/IEC 17025
Defines the requirements for accredited testing laboratories and ensures competence, traceability and reliability of analytical results.

Product-Specific Regulatory Requirements
Additional sterility requirements may apply depending on the product category, route of administration, manufacturing process and intended use.

Microbial identification of contamination in pharmaceutical sterility testing.

Unclear sterility findings, such as turbidity or unexpected growth, are resolved through species-level identification to distinguish true contamination from artefacts.

Learn More

Growth promotion test using culture media for sterility testing validation.

Validated culture media are a prerequisite for reliable sterility testing, ensuring that a negative result reflects true product sterility rather than inadequate media performance.

Learn More

Endotoxin testing of sterile pharmaceutical products in a laboratory environment.

Sterility and endotoxin testing are both essential release parameters for parenteral and other sterile products, together confirming the absence of viable microorganisms and pyrogenic contamination.

Learn more

Focus on Sterility: Safe Products Through Verified Quality